Related Experiment Video
Updated: May 28, 2025

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
Published on: October 2, 2018
Postpartum hormonal contraceptive use in Denmark during 1997-2021
Søren Vinther Larsen1, Anders Pretzmann Mikkelsen2, Kathrine Bang Madsen3
1Neurobiology Research Unit, Copenhagen University Hospital - Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, Denmark.
Objective:
To provide an overview of postpartum hormonal contraceptive (HC) use in Denmark.
Methods:
This descriptive study used National health registries to estimate the cumulative incidence of HC initiation one year after delivery by type, calendar year, and age group among all first- and second-time mothers who delivered during 1997-2021 in Denmark. Timing of initiation is reported as the median time from delivery.
Results:
A total of 676 759 first-time and 552 142 second-time mothers were registered, with a cumulative incidence of HC initiation of 41.0% (95% CI, 40.9-41.1) and 40.5% (40.4-40.6), respectively. From 1997 to 2021, the cumulative incidence of first-time mothers who initially used progestogen-only pills increased from 3.8% (3.5-4.0) to 14.4% (13.9-14.8) and intrauterine levonorgestrel-releasing systems from 0.1% (0.1-0.2) to 12.6% (12.3-13.0). In contrast, combined oral contraception initiation decreased from 31.3% (30.7-31.8) to 7.8% (7.5-8.2). The median time of initiation decreased from 4.7 (Q1-Q3, 2.5-7.5) months during 1997-2001 to 2.5 (2-0-4.0) months during 2017-2021. The cumulative incidence of first-time mothers using combined HC six weeks after delivery decreased from 1.5% (1.5-1.6) during 2007-2011 to 0.5% (0.5-0.5) during 2017-2021.
Conclusions:
Within the first year after childbirth, 41 % of first- and second-time mothers initiated HC in Denmark. Throughout 1997-2021, mothers started earlier after delivery and more often used progestogen-only contraception. Few started combined HC within 6 weeks after delivery. Taken together, the pattern of HC use over time reflects a change to safer contraceptive methods postpartum which minimizes thromboembolic risk.
More Related Videos
06:49Methods for Studying Uterine Contributions to Pregnancy Establishment in an Ovariectomized Mouse Model
Published on: April 7, 2023
06:18An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Related Concept Videos
Birth Control Methods
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
The Menstrual Cycle
The menstrual phase occurs from days 1 to 5 and involves the shedding of the stratum functionalis, as a...
Ovarian Cycle
Secretory Phase
Following ovulation, the corpus luteum, a temporary endocrine structure, produces progesterone and estrogens. These hormones stimulate the growth and coiling of endometrial...